Get my own profile
Public access
View all38 articles
2 articles
available
not available
Based on funding mandates
Co-authors
Mikhail SavitskiEMBLVerified email at embl.de
Nassos TypasGroup Leader, EMBLVerified email at embl.de
Frank SteinEMBL HeidelbergVerified email at embl.de
Nils KurzawaCellzome, a GSK companyVerified email at gsk.com
Per ArturssonUppsala universityVerified email at farmaci.uu.se
Isabelle BecherEMBL HeidelbergVerified email at embl.de
Joel SelkrigRWTH University Hospital, Aachen, GermanyVerified email at ukaachen.de
Pär MatssonProfessor of Pharmacokinetics, Sahlgrenska Academy, University of GothenburgVerified email at gu.se
Dominic HelmProteomics Core Facility, DKFZVerified email at dkfz-heidelberg.de
Thomas LundbäckSenior Director, Mechanistic & Structural Biology, R&D, AstraZenecaVerified email at astrazeneca.com
Manuel BanzhafUniversity of Newcastle, EnglandVerified email at newcastle.ac.uk
Cristina ViéitezInstitute of Funcional Biology and Genomics (IBFG) CSIC-University of SalamancaVerified email at usal.es
Ana Rita BrochadoTübingen University, GermanyVerified email at uni-wuerzburg.de
mike hannGlaxoSmithKlineVerified email at gsk.com
Brinton Seashore-LudlowKarolinska InstitutetVerified email at ki.se
Christine WeglerSenior research engineer, Swedish Metabolomics Center, Umeå UniversityVerified email at umu.se
Anna VildhedeSenior scientist, AstraZenecaVerified email at alumni.chalmers.se
Bede P. BusbyTeam Manager Ministry for Primary Industries, Bacteriology and Aquatic Animal DiseasesVerified email at mpi.govt.nz
Ilaria PiazzaMax Delbrück Center for molecular medicine in the Helmholtz association, MDC Berlin.Verified email at mdc-berlin.de
Felipe CavaUmeå University (Sweden)Verified email at umu.se
Follow
André Mateus
Assistant Professor at Umeå University | Team Leader at Molecular Infection Medicine Sweden (MIMS)
Verified email at umu.se - Homepage